
Activity ID
11386Expires
May 20, 2025Format Type
Journal-basedCME Credit
1Fee
$30CME Provider: JAMA
Description of CME Course
This Viewpoint discusses the challenge prior medication authorization procedures presents for patients, physicians, and practices, and it proposes principles to guide “prior auth” reform, including focusing the procedures on the initial intended purpose of managing use of high-cost drugs that have equivalent lower-cost alternatives, protecting the continuity of medication for patients, and being transparent, efficient, and fair in their requirements.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
To understand the negative impacts on patient care and administrative costs of prior authorization in Dermatology
Keywords
Medical Education, Hypertension
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/jama.2019.21428